ESR1 and neoplasm: Recent publications support this mechanism, stating that ERβ has an anti-proliferative effect by downregulating the expression of ERα, diminishing epithelial–mesenchymal transition, which reduces cell invasion, and induces the entering in G2 phase arrest that promotes the inhibition of tumor growth [110,111].